Abstract
Cyclosporin A (Sandimmune) rapidly induced an increase in daunorubicin accumulation in multidrug-resistant human ovarian carcinoma cells (2780AD) and was more potent than verapamil. Steady-state 3H-cyclosporin A accumulation at 37 degrees C in 2780AD cells was 60-70% of that in the sensitive A2780 cells. A rapid increase of ATP consumption and lactate production was induced in 2780AD cells by verapamil, but not by cyclosporin A. These results suggest that the interactions of cyclosporin A and verapamil with P-glycoprotein, which leads to inhibition of drug transport, have a different mechanistic basis.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Akiyama S., Cornwell M. M., Kuwano M., Pastan I., Gottesman M. M. Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog. Mol Pharmacol. 1988 Feb;33(2):144–147. [PubMed] [Google Scholar]
- Arsenault A. L., Ling V., Kartner N. Altered plasma membrane ultrastructure in multidrug-resistant cells. Biochim Biophys Acta. 1988 Feb 18;938(2):315–321. doi: 10.1016/0005-2736(88)90169-1. [DOI] [PubMed] [Google Scholar]
- Bradley G., Juranka P. F., Ling V. Mechanism of multidrug resistance. Biochim Biophys Acta. 1988 Aug 3;948(1):87–128. doi: 10.1016/0304-419x(88)90006-6. [DOI] [PubMed] [Google Scholar]
- Broxterman H. J., Kuiper C. M., Schuurhuis G. J., Tsuruo T., Pinedo H. M., Lankelma J. Increase of daunorubicin and vincristine accumulation in multidrug resistant human ovarian carcinoma cells by a monoclonal antibody reacting with P-glycoprotein. Biochem Pharmacol. 1988 Jun 15;37(12):2389–2393. doi: 10.1016/0006-2952(88)90365-6. [DOI] [PubMed] [Google Scholar]
- Broxterman H. J., Kuiper C. M., Schuurhuis G. J., van der Hoeven J. J., Pinedo H. M., Lankelma J. Daunomycin accumulation in resistant tumor cells as a screening model for resistance modifying drugs: role of protein binding. Cancer Lett. 1987 Apr;35(1):87–95. doi: 10.1016/0304-3835(87)90060-7. [DOI] [PubMed] [Google Scholar]
- Broxterman H. J., Pinedo H. M., Kuiper C. M., Kaptein L. C., Schuurhuis G. J., Lankelma J. Induction by verapamil of a rapid increase in ATP consumption in multidrug-resistant tumor cells. FASEB J. 1988 Apr;2(7):2278–2282. doi: 10.1096/fasebj.2.7.3350243. [DOI] [PubMed] [Google Scholar]
- Broxterman H. J., Pinedo H. M., Kuiper C. M., Schuurhuis G. J., Lankelma J. Glycolysis in P-glycoprotein-overexpressing human tumor cell lines. Effects of resistance-modifying agents. FEBS Lett. 1989 Apr 24;247(2):405–410. doi: 10.1016/0014-5793(89)81380-8. [DOI] [PubMed] [Google Scholar]
- Chambers S. K., Hait W. N., Kacinski B. M., Keyes S. R., Handschumacher R. E. Enhancement of anthracycline growth inhibition in parent and multidrug-resistant Chinese hamster ovary cells by cyclosporin A and its analogues. Cancer Res. 1989 Nov 15;49(22):6275–6279. [PubMed] [Google Scholar]
- Foxwell B. M., Mackie A., Ling V., Ryffel B. Identification of the multidrug resistance-related P-glycoprotein as a cyclosporine binding protein. Mol Pharmacol. 1989 Oct;36(4):543–546. [PubMed] [Google Scholar]
- Goldberg H., Ling V., Wong P. Y., Skorecki K. Reduced cyclosporin accumulation in multidrug-resistant cells. Biochem Biophys Res Commun. 1988 Apr 29;152(2):552–558. doi: 10.1016/s0006-291x(88)80073-1. [DOI] [PubMed] [Google Scholar]
- Gruber A., Peterson C., Reizenstein P. D-verapamil and L-verapamil are equally effective in increasing vincristine accumulation in leukemic cells in vitro. Int J Cancer. 1988 Feb 15;41(2):224–226. doi: 10.1002/ijc.2910410211. [DOI] [PubMed] [Google Scholar]
- Hamada H., Tsuruo T. Characterization of the ATPase activity of the Mr 170,000 to 180,000 membrane glycoprotein (P-glycoprotein) associated with multidrug resistance in K562/ADM cells. Cancer Res. 1988 Sep 1;48(17):4926–4932. [PubMed] [Google Scholar]
- Haynes M., Fuller L., Haynes D. H., Miller J. Cyclosporin partitions into phospholipid vesicles and disrupts membrane architecture. Immunol Lett. 1985;11(5-6):343–349. doi: 10.1016/0165-2478(85)90118-x. [DOI] [PubMed] [Google Scholar]
- Helson L. Calcium channel blocker enhancement of anticancer drug cytotoxicity--a review. Cancer Drug Deliv. 1984 Fall;1(4):353–361. doi: 10.1089/cdd.1984.1.353. [DOI] [PubMed] [Google Scholar]
- Horio M., Gottesman M. M., Pastan I. ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells. Proc Natl Acad Sci U S A. 1988 May;85(10):3580–3584. doi: 10.1073/pnas.85.10.3580. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Huet S., Robert J. The reversal of doxorubicin resistance by verapamil is not due to an effect on calcium channels. Int J Cancer. 1988 Feb 15;41(2):283–286. doi: 10.1002/ijc.2910410220. [DOI] [PubMed] [Google Scholar]
- Inaba M., Johnson R. K. Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant sublines of P388 leukemia. Biochem Pharmacol. 1978;27(17):2123–2130. doi: 10.1016/0006-2952(78)90284-8. [DOI] [PubMed] [Google Scholar]
- Kessel D. Circumvention of resistance to anthracyclines by calcium antagonists and other membrane-perturbing agents. Cancer Surv. 1986;5(1):109–127. [PubMed] [Google Scholar]
- Leyva A., Appel H., Pinedo H. M. Purine modulation of thymidine activity in L1210 leukemia cells in vitro. Leuk Res. 1982;6(4):483–490. doi: 10.1016/0145-2126(82)90005-4. [DOI] [PubMed] [Google Scholar]
- Nooter K., Oostrum R., Jonker R., van Dekken H., Stokdijk W., van den Engh G. Effect of cyclosporin A on daunorubicin accumulation in multidrug-resistant P388 leukemia cells measured by real-time flow cytometry. Cancer Chemother Pharmacol. 1989;23(5):296–300. doi: 10.1007/BF00292407. [DOI] [PubMed] [Google Scholar]
- Osieka R., Seeber S., Pannenbäcker R., Soll D., Glatte P., Schmidt C. G. Enhancement of etoposide-induced cytotoxicity by cyclosporin A. Cancer Chemother Pharmacol. 1986;18(3):198–202. doi: 10.1007/BF00273385. [DOI] [PubMed] [Google Scholar]
- Peterson C., Baurain R., Trouet A. The mechanism for cellular uptake, storage and release of daunorubicin. Studies on fibroblasts in culture. Biochem Pharmacol. 1980 Jun 15;29(12):1687–1692. doi: 10.1016/0006-2952(80)90126-4. [DOI] [PubMed] [Google Scholar]
- Ramu N., Ramu A. Circumvention of adriamycin resistance by dipyridamole analogues: a structure-activity relationship study. Int J Cancer. 1989 Mar 15;43(3):487–491. doi: 10.1002/ijc.2910430324. [DOI] [PubMed] [Google Scholar]
- Rogan A. M., Hamilton T. C., Young R. C., Klecker R. W., Jr, Ozols R. F. Reversal of adriamycin resistance by verapamil in human ovarian cancer. Science. 1984 Jun 1;224(4652):994–996. doi: 10.1126/science.6372095. [DOI] [PubMed] [Google Scholar]
- Safa A. R., Glover C. J., Sewell J. L., Meyers M. B., Biedler J. L., Felsted R. L. Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers. J Biol Chem. 1987 Jun 5;262(16):7884–7888. [PubMed] [Google Scholar]
- Schuurhuis G. J., Broxterman H. J., van der Hoeven J. J., Pinedo H. M., Lankelma J. Potentiation of doxorubicin cytotoxicity by the calcium antagonist bepridil in anthracycline-resistant and -sensitive cell lines. A comparison with verapamil. Cancer Chemother Pharmacol. 1987;20(4):285–290. doi: 10.1007/BF00262578. [DOI] [PubMed] [Google Scholar]
- Skovsgaard T., Nissen N. I. Membrane transport of anthracyclines. Pharmacol Ther. 1982;18(3):293–311. doi: 10.1016/0163-7258(82)90034-1. [DOI] [PubMed] [Google Scholar]
- Slater L. M., Sweet P., Stupecky M., Wetzel M. W., Gupta S. Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinoma. Br J Cancer. 1986 Aug;54(2):235–238. doi: 10.1038/bjc.1986.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Twentyman P. R. A possible role for cyclosporins in cancer chemotherapy. Anticancer Res. 1988 Sep-Oct;8(5A):985–993. [PubMed] [Google Scholar]
- Twentyman P. R., Fox N. E., White D. J. Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multi-drug resistant human lung cancer cell line. Br J Cancer. 1987 Jul;56(1):55–57. doi: 10.1038/bjc.1987.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Van der Bliek A. M., Baas F., Van der Velde-Koerts T., Biedler J. L., Meyers M. B., Ozols R. F., Hamilton T. C., Joenje H., Borst P. Genes amplified and overexpressed in human multidrug-resistant cell lines. Cancer Res. 1988 Nov 1;48(21):5927–5932. [PubMed] [Google Scholar]
- Vayuvegula B., Slater L., Meador J., Gupta S. Correction of altered plasma membrane potentials. A possible mechanism of cyclosporin A and verapamil reversal of pleiotropic drug resistance in neoplasia. Cancer Chemother Pharmacol. 1988;22(2):163–168. doi: 10.1007/BF00257315. [DOI] [PubMed] [Google Scholar]
- Walker R. J., Lazzaro V. A., Duggin G. G., Horvath J. S., Tiller D. J. Cyclosporin A inhibits protein kinase C activity: a contributing mechanism in the development of nephrotoxicity? Biochem Biophys Res Commun. 1989 Apr 14;160(1):409–415. doi: 10.1016/0006-291x(89)91671-9. [DOI] [PubMed] [Google Scholar]
- Zamora J. M., Pearce H. L., Beck W. T. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells. Mol Pharmacol. 1988 Apr;33(4):454–462. [PubMed] [Google Scholar]